ÉÂÍý³ØÂèÆó¹ÖºÂ
¡Ô¸¦µæ³µÍסÕ
£É¡¥Å·Á³»ºÊª¤Ë¤è¤ëÆý´âÍÞÀ©¤Î»î¤ß
¡¡ÂçÆ¦¤Ë´Þ¤Þ¤ì¤ëGenistein¤äµûÌý¤Ë¸ºß¤¹¤ën-3·Ï¿²ÁÉÔ˰Ï»éËûÀ¤Ç¤¢¤ë¥¨¥¤¥³¥µ¥Ú¥ó¥¿¥¨¥ó»À¡ÊEPA¡Ë¤ÏÆý´â¤ËÂФ·¤ÆÁý¿£ÍÞÀ©ºîÍѤòͤ·¡¢¤³¤ì¤éξ¼Ô¤ÎÊ»ÍѤˤè¤êÁê¾èŪ¤ËºîÍѤ¹¤ë¤³¤È¤ò¾ÚÌÀ¤·¤¿¡ÊJ Cancer Res Clin Oncol 126: 448-454, 2000¡Ë¡£ÆüËܿͤÏÂçÆ¦¤ò¾ï¿©¤È¤·¡¢µû¤ò¹¥¤à¤¬¡¢¤³¤Î¥Ç¡¼¥¿¤ÏÆüËÜÉ÷¿©½¬´·¤ÎºÆÉ¾²Á¤Ë¤è¤ë´âͽËɤ˼¨º¶¤ò¤¢¤¿¤¨¤ë¤³¤ÈÂç¤È¹Í¤¨¤ë¡£²æ¡¹¤Ï¤µ¤é¤Ë¡¢±Ö³Ø¤Î¼¨¤¹´âÍÞÀ©µ¡Ç½¤òͤ¹¤ë¿©Éʰø»Ò¤ÎÆý´âÍÞÀ©µ¡Ç½¤Ë¤Ä¤¼Â¸³¼¼¥ì¥Ù¥ë¤Ç¸¡Æ¤¤·¤¿¡£¥Õ¥é¥ó¥¹¿Í¤Ï¹â»éËÿ©¤Î¿©½¬´·¤Ë¤â¤«¤«¤ï¤é¤º¡¢¿´·ì´ÉÉÂÊѤÎȯÀ¸Î¨¤¬Ä㤤¤³¤È¤ò¡ÈFrench paradox¡É¤È¤¤¤¦¤¬¡¢¤³¤ÎÍ×°ø¤È¤·¤ÆÀ֥磻¥ó¤ËËÉ٤˴ޤޤì¤ëResveratrol¤È¤Î´ØÏ¢¤¬ÃíÌܤµ¤ì¤Æ¤¤¤ë¡£Resveratrol¤Ë¤Ï³Æ¼ï¥Ò¥ÈÇÝÍܼðáçºÙ˦³ô¤ËÂФ¹¤ëºÙ˦Áý¿£ÍÞÀ©¸ú²Ì¤¬¤¢¤ë¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¤³¤È¤è¤ê¡¢¥Ò¥ÈÆý´âÇÝÍܺÙ˦³ô¤ËÂФ¹¤ëºÙ˦Áý¿£ÍÞÀ©¸ú²Ì¡¢¤Ê¤é¤Ó¤ËÆý´âÁý¿£ºîÍѤò¤â¤Ä¥ê¥Î¡¼¥ë»À¤ËÂФ¹¤ëÙɹ³ºîÍѤˤĤ¸¡Æ¤¤·¤¿¡Ê¸¶Ãø1¡Ë¡£Resveratrol¤ÏMCF-7¡¢KPL-1¡¢MKL-F¤Î3³ô¤È¤â»þ´Ö°Í¸À¡¢Ç»Åٰ͸À¤ËºÙ˦Áý¿£ÍÞÀ©¸ú²Ì¤¬¤ß¤é¤ì¤¿¡£¤Þ¤¿¡¢Resveratrolź²Ã¤Ë¤è¤ê¡¢Bax¡¢Bak¤ÎÁý²Ã¡¢Bcl-XL¤Î¸º¾¯¡¢Caspase-3³èÀ¤Î¾å¾º¤ò¤ß¤¿¡£¤µ¤é¤Ë¡¢Resveratrol¤Ï¥ê¥Î¡¼¥ë»À¤ÎºÙ˦Áý¿£³èÀ¤ËÙɹ³¤·¤¿¡£Resveratrol¤Ï¥¢¥Ý¥È¡¼¥·¥¹¤ò²ð¤¹¤ëºÙ˦Áý¿£ÍÞÀ©¸ú²Ì¤ò¼¨¤·¡¢À¾²¤É÷¹â»éËÿ©¡Ê¹â¥ê¥Î¡¼¥ë»À¿©¡Ë¤Ë¤è¤ëÆý´âÁý¿£Â¥¿ÊºîÍѤËÙɹ³¤¹¤ë¡£¤µ¤é¤Ë¡¢±Ö³ØÅª¤Ëµ¡Ç½À¿©ÉʤȤ·¤Æ´âͽËɸú²Ì¤¬ºÇ¤â´üÂÔ¤µ¤ì¤ë¥Ë¥ó¥Ë¥¯¤Ë´Þ¤Þ¤ì¤ë»éÍÏÀ¥¤¥ª¥¦²½¹çʪ¤Ç¤¢¤ëdiallyl disulfide¡ÊDADS¡Ë¤ÎÆý´âÍÞÀ©¸ú²Ì¤Ë¤Ä¤¥Ò¥ÈÆý´âºÙ˦³ô¡ÊKPL-1¡¢MCF-7¡¢MDA-MB-231¡¢MKL-F¡Ë¤òÍѤ¤¤Æ¸¡Æ¤¤·¤¿¡Ê¸¶Ãø6¡Ë¡£MTT¥¢¥Ã¥»¥¤¤Ë¤è¤ë¤È¡¢¤¤¤º¤ì¤ÎºÙ˦³ô¤âÁý¿£ÍÞÀ©¤ò¤ß¤¿¡£MDA-MB-231³ô¤ËDADS¤òź²Ã¤·¡¢¥Õ¥í¡¼¥µ¥¤¥È¥á¥È¥ê¡¼¤Ç²òÀϤ·¤¿¤È¤³¤í¡¢SubG1ʬ²è¤Î½Ð¸½¤òǧ¤á¤¿¡£KPL-1ºÙ˦³ô¤ò¥Ì¡¼¥É¥Þ¥¦¥¹±¦¶»ÉôÆýÁ£¤ËÀµ½êÀ°Ü¿¢¤·¡¢1mg¤¢¤ë¤¤¤Ï2mgDADS¤ò½µ3²óÊ¢¹ÐÆâÅêÍ¿¤·¡¢°Ü¿¢¼ðáç¤ÎÁý¿£¤ò̵½èÃÖ·²¤ÈÈæ³Ó¤¹¤ë¤È¡¢DADS½èÃÖ·²¤Ç¤Ï¼ðáçÁý¿£¤ÎÃٱ䤬¤ß¤é¤ì¡¢°Ü¿¢¸å35ÆüÌܤǤϳƤμðáç½ÅÎ̤Ï̵½èÃÖ·²¤Î57¡ó¤Ë¤È¤É¤Þ¤Ã¤¿¡£¤Þ¤¿¡¢DADS¤Ï¥ê¥Î¡¼¥ë»À¤ÎÆý´âÁý¿£¸ú²Ì¤ËÙɹ³¤·¡¢EPA¤È¤ÎÊ»ÍѤÇÁê¾è¸ú²Ì¤òȯ´ø¤·¤¿¡£DADS¤Ï¥Ò¥ÈÆý´âºÙ˦³ô¤ÎÁý¿£¤òÍÞÀ©¤¹¤ë¤È¤È¤â¤Ë¡¢À¾²¤É÷¹â»éËÿ©¡Ê¹â¥ê¥Î¡¼¥ë»À¿©¡Ë¤Ë¤è¤ëÆý´âÁý¿£Â¥¿ÊºîÍѤËÙɹ³¤·¡¢ÆüËÜ¿©¡Ê¹âEPA¿©¡Ë¤Ë¤è¤ëÆý´âÍÞÀ©¸ú²Ì¤òÁý¶¯¤¹¤ë¡£¿©Éʰø»Ò¤Ë¤Ï´âÍÞÀ©¸ú²Ì¤òȯ´ø¤¹¤ë¼ï¡¹¤ÎÅ·Á³Êª¼Á¤¬´Þ¤Þ¤ì¤ë¡£¤³¤ì¤é¤ÏñÆÈ¤Ë¤¢¤ë¤¤¤ÏÊ£¹çŪ¤ËºîÍѤ·¡¢¥¢¥Ý¥È¡¼¥·¥¹¤ò²ð¤·¤ÆÁý¿£ÍÞÀ©Ç½¤òȯ´ø¤¹¤ë¡£´âͽËɤδÑÅÀ¤«¤é¤â¤³¤ì¤éÅ·Á³»ºÊª¤ÎƱÄê¤Ï½ÅÍפȹͤ¨¤ë¡£
¶¡¥¼Â¸³ÅªÉû¿ÕÂ´Ãæ¤Îµ¡½ø²òÀÏ
¡¡Â¿´Ä˧¹á²ú²½¿åÁǤǤ¢¤ë7, 12-dimethylbenz (a) anthracene¡ÊDMBA¡Ë¤Ï¥é¥Ã¥È¤ËÆý´â¤äÇò·ìɤòͶȯ¤¹¤ëȯ´âºÞ¤Ç¤¢¤ë¡£DMBA¤Ë¤è¤ë¥é¥Ã¥ÈÉû¿ÕÂ´Ãæ¤Ï1961ǯ¤Ë¸µËֺܹ¼çǤ¡¢¿¹°æ³°µÈ̾ÍÀ¶µ¼ø¤¬ChicagoÂç³ØBen May´â¸¦µæ½ê¤ÎC.B. Huggins¶µ¼ø¤Î¤â¤È¤ÇÆý´â¤Î¸¦µæÃæ¤Ë¶öÁ³¤Ë¸«¤¤½Ð¤·¤¿¸½¾Ý¤Ç¤¢¤ë¡£30mg DMBA¤ò2ml¤Î¥´¥ÞÌý¤ËÍϲò¤·Ã±²ó°ßÆâÅêÍ¿¤¹¤ë¤«¡¢6mg DMBA´ÞÍ1.2ml¤Î»éËÃÆýºÞ¤òñ²óÀÅÃí¤¹¤ë¤È¹âΨ¤ËÉû¿Õ½Ð·ì¤¬¾·Í褷¡¢Èé¼ÁºÙ˦»à¤ò¼æµ¯¤·¡¢¤¢¤ë¸ÄÂΤÏÀг¥²½Áã¤ò»Ä¤·¤ÆÈé¼ÁºÙ˦¤ÎºÆÀ¸¤ò¤ß¤ë¡£Éû¿Õ¾ã³²¤Ï«¾õÁؤÈÌÖ¾õÁؤ˸¶ɤ·¡¢µå¾õÁؤä¿ñ¼Á¤Ï¾ã³²¤ò¤Þ¤Ì¤¬¤ì¤ë¡£¤·¤«¤·¡¢º£Æü¤Þ¤Ç«¾õ¡¿ÌÖ¾õÁؤκÙ˦»à¤¬¤¤¤«¤Ê¤ëµ¡Å¾¤Ë¤è¤ë¤â¤Î¤«³ÎÄꤷ¤Æ¤¤¤Ê¤¤¡£²æ¡¹¤Ï¾ïË¡¤Ë§¤êÉû¿ÕÂ´Ãæ¤ò¼æµ¯¤»¤·¤á¡¢¤³¤Îµ¡¹½²òÌÀ¤Ë¤È¤ê¤¯¤ó¤À¡Ê¸¶Ãø5¡Ë¡£DMBAÅêÍ¿12»þ´Ö¤Ç¾ã³²ºÙ˦¤ÏTUNELÍÛÀ¤È¤Ê¤ê¡¢36»þ´Ö¤ÇTUNEL»Ø¿ô¤Ï¶ËÃͤòÄ褹¤ë¡£·Ð²áÃæ¡¢Èé¼ÁºÙ˦¤Ï·ÁÂÖŪ¤Ë¤âÆÃͤΥ¯¥í¥Þ¥Á¥ó¤Î³Ë±ï¤Ø¤Î¶Å½¸¤¬¤ª¤³¤ê¡¢ºÙ˦»à¤Ïapoptosis¤È¤¤¤¨¤ë¡£¤µ¤é¤Ë¡¢¤³¤Î»þ´ü¡¢¥¢¥Ý¥È¡¼¥·¥¹¤ËÂ¥¿ÊŪ¤ËƯ¤¯BaxÃÁÇò¤Îȯ¸½Ð¶¿Ê¤ä¥«¥¹¥Ñ¡¼¥¼3¤Î³èÀÁý¶¯¡¢¥¢¥Ý¥È¡¼¥·¥¹¤ËÍÞÀ©Åª¤ËƯ¤¯Bcl-2ÃÁÇò¤Îȯ¸½ÍÞÀ©¤ò¤ß¤¿¡£¤·¤«¤·¡¢ÂçÎ̽зì¤ÎȯÀ¸¤È¤È¤â¤Ë¶É½ê¤Ëµõ·ì¤¬Í¶È¯¤µ¤ì¶Å¸Ç²õ»à¡Êpost-apoptotic necrosis¡Ë¤ÎȯÀ¸¤ò¤ß¤¿¡£¤Ê¤ª¡¢72»þ´Ö¤«¤é5-bromo-2¡Ç-deoxyuridine¡ÊBrdU¡ËÍÛÀºÙ˦¤¬µå¾õÁؤβ¼ÁءʰܹÔÂӡˤ˽и½¤·¡¢·Ð»þŪ¤Ë¿ñ¼Á¤Ë¸þ¤±¤ÆÍÛÀºÙ˦¿ô¤òÁý¤·¡¢¤³¤ì¤éºÙ˦¤Ïp450 11¦ÂÍÛÀ¤òÄ褹¤ë¤³¤È¤«¤é¡¢°Ü¹ÔÂӤ˸ºß¤¹¤ëºÙ˦¤¬Éû¿ÕÈé¼Á¤ÎºÆÀ¸¤Ë´ØÍ¿¤¹¤ë´´ºÙ˦¤È¹Í¤¨¤é¤ì¤¿¡£¤Ê¤ª¡¢2½µ¤Ë¤ª¤¤¤Æ¤Ï°ìÉô¤ÎÉû¿Õ¤ËÇÏÄý·¿¤òÄ褹¤ëÀг¥²½Áã¤ò»Ä¤·¤Æ½¤Éü¤Ï´°Î»¤·¤¿¡£¤è¤Ã¤Æ¡¢DMBA¤Ë¤è¤ëÉû¿ÕÂ´Ãæ¤È¤Ïapoptosis¤Ë¤è¤ë«¾õ¡¿ÌÖ¾õÁغÙ˦¤ÎÁªÂòŪ¾ã³²¤Ç¤¢¤ê¡¢Èé¼ÁºÙ˦¤ÎºÆÀ¸¤Ï°Ü¹ÔÂӤ˸ºß¤¹¤ë´´ºÙ˦¤Ë¤è¤ë¤È·ëÏÀ¤Ç¤¤¿¡£
¡Ô¸¦µæ¶ÈÀÓ¡Õ
¸¶¡¡¡¡Ãø
-
Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K and Tsubura A (2001)
Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator.
J Cancer Res Clin Oncol 127: 258-264
- Kiyozuka Y, Tsuta K, Akamatsu T, Matsuyama T, Mizuta H, Nakanishi K, Nakano S and Tsubura A (2001)
Cytologic features of primary mixoid malignant fibrous histiocytoma arizing in the uterus.
Acta Cytol 45: 1060-1068
- Kiyozuka Y, Nakagawa H, Uemura Y, Senzaki H, Yamamoto A, Noguchi T, Mizuta H, Nakanishi K, Nakano S and Tsubura A (2001)
Novel cell lines established from a human myxoid malignant fibrous histiocytoma arizing in the uterus.
Cancer Genet Cytogen 127: 7-15
- Shimizu M, Fontana A, Takeda Y, Yoshimoto T, Tsubura A and Matsuzawa A (2001)
Fas/Apo1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
Cell Immunol 207: 41-48
- Tsuta K, Shikata N, Kominami S and Tsubura A (2001)
Mechanisms of adrenal damage induced by 7, 12-dimethylbenz (a) anthracene in female Sprague-Dawley rats.
Exp Mol Pathol 70: 162-172
- Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K and Tsubura A (2001)
Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
Carcinogenesis 22: 891-897
- Yasuda T, Yoshimoto T, Tsubura A and Matsuzawa A (2001)
Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-1 2p40 transgene in MRL-Fas lprcg / Fas lprcg mice.
Cell Immunol 210: 77-86
- Kiyozuka Y, Mizuta H, Nakanishi K, Nakano S and Tsubura A (2001)
Malignant fibrous histiocytoma of the uterus : a case with immunohistochemical, ultrastructural and tumor cell culture studies.
In Vivo 15: 227-231
- Kiyozuka Y, Nakagawa H, Senzaki H, Uemura Y, Adachi S, Teramoto Y, Matsuyama T, Bessho K and Tsubura A (2001)
Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer.
Anticancer Res 21: 1723-1730
- Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A and Kuwahara T (2001)
Intraglomerular metastasis from pancreatic cancer.
Am J Kidney Dis 37: 1299-1303
- ÃæÀǷ¡¤À¶Ä͹¯É§¡¤¿¢Â¼Ë§»Ò¡¤Àçºê±Ñ¿Í¡¤»ÍÊý¿ÌÀ¡¤ÅÄÃæ´°»ù¡¤ÆüÃֹɻÎϺ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
Resveratrol¤Ë¤è¤ë¥Ò¥ÈÆý´âÇÝÍܺÙ˦³ô¤ËÂФ¹¤ëÁý¿£ÍÞÀ©¸ú²Ì¡¥
Æý´â´ðÁø¦¡¡10: 62-65
- ÍÌ¡¡·Ñ¹È¡¤µÁß·¹îɧ¡¤ÃæÀǷ¡¤»ÍÊý¿ÌÀ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¼þÀ¸´ügenistein˽Ϫ¤Ë¤è¤ëICR¥Þ¥¦¥¹ÆýÁ£ÉÂÊѤؤαƶÁ¡¥
Æý´â´ðÁø¦¡¡10: 7-11
- »ÍÊý¿ÌÀ¡¤µÁß·¹îɧ¡¤ÌÚÆâ¹î¼£¡¤ÍÌ¡¡·Ñ¹È¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
MNUͶȯ¿·À¸»Æ´üæÌӾɥâ¥Ç¥ë¤òÍѤ¤¤¿Cepharanthin¤ÎæÌÓÃÙ±ä¸ú²Ì¡¥
¥¢¥ë¥«¥í¥¤¥É¸¦µæ²ñ»ï¡¡27: 95-102
- Àçºê±Ñ¿Í¡¤¾åÅÄ¡¡Øª¡¤¿¢Â¼Ë§»Ò¡¤ÃæÀǷ¡¤ÄÕ¡¡¹¬¼£¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
ÂçIJ´â¤òͤ·¤¿Cronkhite-Canada¾É¸õ·²¤Î1Îã¡¥
´â¤ÎÎס¡47: 161-166
- »³ËÜÂç¸ç¡¤ÅÄÃæ´°»ù¡¤´äËÜ»üǽ¡¤¹âÅĽ¨Ê桤¸¢Æ£½¨¼ù¡¤Àçºê±Ñ¿Í¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¿²ÁÉÔ˰Ï»éËûÀ¤Ë¤è¤ë¼ðáçÁý¿£¤Î´ØÍ¿¡¥
JJPEN¡¡23: 335-341
- À§»Þ¡¡·É¡¤ÈªÇ¸Éðɧ¡¤ÃæÀǷ¡¤ÆüÃֹɻÎϺ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¾®ÍÕ·ÁÀ®¤òȼ¤¦½÷À²½Æý˼¾É¤Î°ì¾ÉÎã¡¥
Æý´â¤ÎÎס¡16: 519-522
- ÂΩ¡¡Ì÷¡¤¾®ÌøÄÅε¼ù¡¤Àçºê±Ñ¿Í¡¤ËÙ°æ»ÌÉס¤²®Ìî×¢ÂÀϺ¡¤ÃæÂ¼¾´Íø¡¤Â¼¾åµ®¹§¡¤¾®ÌøÄż£¼ù¡¤ÃÓÂÞ°ìºÈ¡¤ÃÓ¸¶¡¡¿Ê¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¶Ý¤Ë¤è¤ëWaterhouse-Friderichsen¾É¸õ·²¤Î1˶¸¡Îã¡¥
¾®»ùÎס¡54: 2039-2042
Áí¡¡¡¡Àâ
- Senzaki H, Tsubura A and Takada H (2001)
Effect of eicosapentaenoic acid on the suppression of growth and metastasis of human breast cancer cells in vivo and in vitro.
World Rev Nutr Diet 88: 117-125
- ÍæÎɰ¦Ïº¡¤»ÍÊý¿ÌÀ¡¤Àçºê±Ñ¿Í¡¤¿¢Â¼Ë§»Ò¡Ê2001¡Ë
ÆýÁ£»é¼ÁʬÈç´â¡¥
ÉÂÍý¤ÈÎס¡19: 496-499
³Ø²ñȯɽ
- Nambu H, Yamada H, Kikuchi K, Matsumura M, Yoshizawa K and Tsubura A (2001)
Light inhibition reduces MNU-induced photoreceptor apoptosis.
ARVO, Fort Lauderdale, Florida
- Kiyozuka Y, Nakagawa H, Tsuta K, Kiuchi K, Senzaki H and Tsubura A (2001)
X-ray microimaging of mitochondrial distribution of cisplatin: Cisplatin-induced mitochondrial dysfunction and apoptosis in ovarian cancer cells.
The 12th International Meeting on Gynaecological Oncology, Venice, Italy
- »ÍÊý¿ÌÀ¡¤µÁß·¹îɧ¡¤ÃæÀǷ¡¤ÄÕ¡¡¹¬¼£¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¼þÀ¸´ügenistein˽Ϫ¤Ë¤è¤ëICR¥Þ¥¦¥¹ÆýÁ£ÉÂÊѤؤαƶÁ¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- Àçºê±Ñ¿Í¡¤»ÍÊý¿ÌÀ¡¤¿¢Â¼Ë§»Ò¡¤À¶Ä͹¯É§¡¤¾åÅÄ¡¡Øª¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
°ÀËö¾¿¿À·Ð¾ä¼ð¤ò¿ȯ¤·¤¿¿À·ÐÀþ°Ý¼ð¾É1·¿¤Î°ìÎã¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- À¶Ä͹¯É§¡¤ÃæÀǷ¡¤ÄÕ¡¡¹¬¼£¡¤ÌÚÆâ¹î¼£¡¤Àçºê±Ñ¿Í¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
Myxoid MFH¤Ë¤ª¤±¤ëºÙ˦ÀÜÃåʬ»Ò¤Îȯ¸½¤ª¤è¤Ó¥Û¥ë¥â¥ó±þÅúǽ¤Ë¤Ä¤¤¤Æ¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- ÃæÀǷ¡¤ÌÚÆâ¹î¼£¡¤ÄÕ¡¡¹¬¼£¡¤À¶Ä͹¯É§¡¤Àçºê±Ñ¿Í¡¤ÅÄÃæ´°»ù¡¤»ÍÊý¿ÌÀ¡¤ÆüÃֹɻÎϺ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
¥Ò¥ÈÆý´âÇÝÍܺÙ˦³ô¤ËÂФ¹¤ëdiallyl disulfide¤ÎÁý¿£ÍÞÀ©¸ú²Ì¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- ÄÕ¡¡¹¬¼£¡¤ÍæÎɰ¦Ïº¡¤ÀÆÌÚÌмù¡Ê2001¡Ë
·ìµåìÅ¿©¾É¸õ·²¤òȼ¤Ã¤¿Langerhans cell histiocytosis¤Î°ìÎã¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- ÌÚÆâ¹î¼£¡¤µÁß·¹îɧ¡¤ÄÕ¡¡¹¬¼£¡¤ÃæÀǷ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
MNUͶȯ¥Þ¥¦¥¹ÌÖËìÊÑÀ¾É¤ËÂФ¹¤ë¥Ë¥³¥Á¥ó¥¢¥ß¥É¤Î±Æ¶Á¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- ¿·Âð²í¹¬¡¤ÄÕ¡¡¹¬¼£¡¤Æî¡¡µá¡¤µÈÅĽ¨É§¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
´ãâÛ¤«¤éÎÞµÖÉô¤Ë¤«¤±¤ÆÈ¯À¸¤·¤¿¥¢¥Ý¥¯¥ê¥ó²½À¸´â¤Î1Îã¡¥
Âè90²óÆüËÜÉÂÍý³Ø²ñ¡¤Åìµþ
- ȪǸÉðɧ¡¤À§»Þ¡¡·É¡¤Æó³¬Æ²ÂÙ»ñ¡¤¿¢Â¼Ë§»Ò¡¤Àçºê±Ñ¿Í¡¤À¶Ä͹¯É§¡¤ÆüÃֹɻÎϺ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
ÆýÁ£Ç´±Õ´â7Îã¤Î¸¡Æ¤¨¡¿À·ÐÆâʬÈç¤Ø¤Îʬ²½¤È¤Î´ØÏ¢¨¡¡¥
Âè9²óÆüËÜÆý´â³Ø²ñÁí²ñ¡¤Á°¶¶
- ÃæÀǷ¡¤ÅÄÃæ´°»ù¡¤ÉÙ±ÊÍ´»Ê¡¤»³ËÜÂç¸ç¡¤ÍæÎɰ¦Ïº¡¤ÆüÃֹɻÎϺ¡Ê2001¡Ë
EPA¤ÈGenistein¤Ë¤è¤ë¥Ò¥ÈÆý´âºÙ˦Áý¿£ÍÞÀ©¤Ë¤ª¤±¤ëÁê¾è¸ú²Ì¡¥
Âè9²óÆüËÜÆý´â³Ø²ñÁí²ñ¡¤Á°¶¶
- µÁß·¹îɧ¡¤ÌÚÆâ¹î¼£¡¤ÆîÉô͵Ƿ¡¤Àçºê±Ñ¿Í¡¤À¶Ä͹¯É§¡¤»ÍÊý¿ÌÀ¡¤ÍæÎɰ¦Ïº¡Ê2001¡Ë
Caspase-3Á˳²ºÞ¤Ë¤è¤ërd¥Þ¥¦¥¹ÌÖËìÊÑÀ¾É¤ÎÍÞÀ©¸ú²Ì¡¥
Âè60²óÆüËÜ´â³Ø²ñ¡¤²£ÉÍ
- À¶Ä͹¯É§¡Ê2001¡Ë
ÍñÁãÌÀºÙ˦Á£´â¤ÎglycogenÂå¼Õ¤«¤é¤ß¤¿¹³´âºÞÂÑÀµ¡¹½¡¥
Âè19²ó¥Ò¥ÈºÙ˦³Ø²ñ¡¤Åìµþ
- ÇÏÅÂŰÌ顤»³Æ»·¼¸ã¡¤Àçºê±Ñ¿Í¡¤Àõ°æ¡¡¹¸¡¤Æ»±º¡¡Âó¡¤Ãæ°æ¹¨¼£¡¤Ã溬¶³»Ê¡¤ÍæÎɰ¦Ïº¡¤ÆüÃֹɻÎϺ¡Ê2001¡Ë
N-nitorosomethylbenzylamine¥é¥Ã¥È¿©Æ»´âȯ´â¥â¥Ç¥ë¤Ë¤ª¤±¤ëȯ´â²áÄø¤Î¸¡Æ¤¡¥
Âè56²óÆüËܾò½´ï³°²Ê³Ø²ñ¡¤½©ÅÄ
Ê¿À®13ǯ¶ÈÀÓÌÜÏ¿°ìÍ÷¤ËÌá¤ë